Argutus Medical would like to introduce you to the Qualigen FastPack® IP αGST Immunoassay, an assay for the in-vitro quantitative determination of αGST in human serum and plasma.

Detection of GST subclass levels in biological fluids is of significant use in monitoring the integrity of specific hepatic regions in the liver.
Since αGST has been found to be equally distributed in both the centrilobular and periportal regions of the liver, αGST would be a more sensitive indicator of hepatocellular status of individuals. The FastPack® IP αGST Immunoassay is designed for use with the FastPack® IP System.

What is the FastPack® IP System?
Features
Results in only 7 Minutes!
One Touch Operation
Lab Quality Precision
Increased Revenue
Patient Side Testing
Increase Office Efficiency

The Qualigen FastPack® IP System is the only quantitative immunoassay analyzer which features one-touch operation in delivering values for Thyroid Stimulating Hormone (TSH), free Thyroxine (free T4), Human Chorionic Gonadotropin (hCG), Prostate Specific Antigen (PSA), free PSA (sold outside the United States), and Testosterone. The system is simple, compact and provides laboratory accuracy in minutes.
The analyzer can be run by any non-technical personnel to provide laboratory quality test results in minutes.

To request more information on this exciting new assay and the FastPack® IP System, please visit the Qualigen website, www.qualigeninc.com.